inVentiv launches company to consolidate European services

Thursday, August 25, 2011 01:53 PM

inVentiv Health will encompass advertising, PR, public policy, market access, med ed, marketing, branding and digital services in a unified offering serving Europe, according to InPharm.

The company has its global headquarters in the US and has grown over the last decade by acquiring numerous independent agencies, including ad agency Junction 11 and PR agency Chandler Chicco.  Now the group’s diverse brands will be consolidated under the InVentiv name.

"All of inVentiv Health’s existing communications brands, along with their many industry clients, will benefit from this enhanced model that addresses growing opportunities in healthcare. Never before has there been a better time for us to more proactively encourage and assure access to the wide range of industry talent available through our communications agencies," said Paul Meister, chief executive of inVentiv Health.

Advertising agencies such as GSW Europe and Junction 11 will now operate as inVentiv Health Communications/Europe, while other companies, such as Chandler Chicco Companies, will continue with their brand names, but now operate under the auspices of the new ‘super agency,’ inVentiv Health Communications/Europe. 

inVentiv Health Communications/Europe will be led by Bob Chandler, senior VP of marketing and communications of inVentiv Health and founder of Chandler Chicco Companies.

“Our new way of going to market is designed to facilitate a multi-disciplinary approach to driving plans and program that reach intended target audiences with greater speed and relevancy. We believe this efficiency will generate financial savings for our clients,” said Chandler.

The new arrangements mean the company’s key communications disciplines will all be located on one site in London.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs